Effect of Nutrition Supplementation Combined With Resistance Exercise in Elderly With Sarcopenia.
NCT ID: NCT05035121
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2017-03-24
2018-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Protein-Enriched Lacto-Vegetarian Soup on Muscle Mass and Muscle Strength Among Older Adults
NCT05243472
Nutrition Ameliorates the Muscle Loss of Pre-sarcopenia in Elderly
NCT07309120
Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia
NCT04516421
Effects of Dietary Supplements on Sarcopenic Elders
NCT03860194
Dose Response of Whey and Soy Protein Ingestion With and Without Resistance Exercise in Elderly Men
NCT01062711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
milk supplement
The milk group provided 200 mL milk two times per day. The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.
milk supplement
Intervention groups provided 200 mL long life milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)
resistance exercise
The participants joined the resistance exercise training program, three times per week (30 min/time)
soy milk supplement
The soy milk group provided 200 mL soy milk two times per day. The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.
soy milk supplement
Intervention groups provided 200 mL long life soy milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)
resistance exercise
The participants joined the resistance exercise training program, three times per week (30 min/time)
control
The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.
resistance exercise
The participants joined the resistance exercise training program, three times per week (30 min/time)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
milk supplement
Intervention groups provided 200 mL long life milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)
soy milk supplement
Intervention groups provided 200 mL long life soy milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)
resistance exercise
The participants joined the resistance exercise training program, three times per week (30 min/time)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No allergies to milk and soy milk
* Sarcopenia cases (AWGS)
* Active ability
Exclusion Criteria
* Last stage of cancer
* Chronic kidney disease stage 4
65 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jiun-Rong Chen
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University
New Taipei City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N201702034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.